A 52 kDa polypeptide in rat liver microsomes was identified as a glucose-binding protein by its ability to weakly bind cytochalasin B and by its cross-reactivity to an antibody raised against the human erythrocyte glucose transport protein.
INTRODUCTION
Glucose is the primary energy source for virtually all mammalian cells, and glucose transport across the plasma membrane is mediated by one or more of a family of glucose-specific transport proteins (e.g. Wheeler & Hinkle, 1985; Simpson & Cushman, 1986; Thorens et al., 1988 Thorens et al., , 1990 Bell et al., 1990) . Blood glucose concentrations are maintained primarily by the balance between uptake of glucose into peripheral tissues and storage by or release from the liver (Ferrannini et al., 1985) . The hepatic microsomal glucose-6-phosphatase enzyme (EC 3.1.3.39) catalyses the terminal step of both gluconeogenesis and glycogenolysis and is therefore a key step in the regulation of blood glucose concentrations by the liver (Ashmore & Weber, 1959; Nordlie, 1985) . Glucose-6-phosphatase is a multi-component system, with the catalytic subunit of the enzyme located within the lumen of the endoplasmic reticulum (ER), and a calciumbinding regulatory protein predominantly located on the cytosolic side of the ER. Three transport proteins are also required. T1 mediates the entry of the substrate glucose 6-phosphate into the lumen of the ER, and T2 is an antiport protein allowing the entry of an alternative substrate (pyrophosphate) and the exit of the product (phosphate) from the lumen of the ER (see Burchell, 1990 , for a recent review). The route by which glucose, released by the action of glucose-6-phosphatase, leaves the lumen of the ER is an unresolved problem, but the protein involved has been designated 'T3" Genetic deficiencies of the enzyme, the regulatory protein, T1 and T2 have been described (see Burchell, 1990 , for a recent review). In addition, the enzyme, the regulatory protein and T2 have all been purified (see Burchell, 1990 , for a recent review). In contrast, no deficiencies of T3 have been described and nothing at all is known about the protein or proteins that transport glucose across the ER membrane. The existence of T3 has become somewhat controversial, e.g. it has been suggested that glucose crosses the ER membrane by simple diffusion (Arion et al., 1980) , whereas kinetic data have indicated that T3 does exist (Nordlie et al., 1986) . We have proposed that glucose transport across the ER membrane also requires the presence of a glucose transport protein or proteins . The aim of this study was therefore to determine whether or not an ER glucose transport protein(s) exists.
In this paper, we have used a number of techniques to identify two possible hepatic microsomal glucose transport proteins. One Abbreviations used: ER, endoplasmic reticulum; PBS, phosphate-buffered saline.
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Vol. 275 of the proteins has now been purified to homogeneity, and an antibody raised against this protein was used to establish its role in the microsomal glucose-6-phosphatase system.
MATERIALS AND METHODS

Materials
Glucose 6-phosphate (monosodium salt), mannose 6-phosphate (monosodium salt), cytochalasin B, 2,5-diphenyloxazole, hydroxysuccinimidyl-4-azidobenzoate and prestained molecular mass markers were obtained from BDH, Poole, Dorset, U. 
Preparation of microsomal fractions
Rat and human liver microsomes were prepared as previously described , except that the microsomal pellet was resuspended to 20 mg/ml in 0.25 M-sucrose/25 mMTris acetate/20 mM-NaF, pH 7.4 (buffer A). The microsomes were then passed down a Sepharose 4B-concanavalin A affinity column as described by Semmi et al. (1982) (Burchell & Cain, 1985) . The gradient was centrifuged at 105 000 g for 18 h before the gradient was fractionated into 1 ml aliquots. Fractions containing glucose-6-phosphatase activity were pooled. A sample of the pooled fractions (2-3 ml) was passed down a Sephadex G-25M column which had previously been equilibrated with buffer A. Fractions containing protein were dialysed against phosphate-buffered saline (PBS, pH 8.0; Waddell Waddell & Burchell (1987) and Waddell et al. (1989) . Antiserum to the 52 kDa polypeptide An antiserum to the purified 52 kDa polypeptide was raised in an adult Cheviot sheep as previously described (Waddell & Burchell, 1988) . IgG was further purified by (NH4)2S04 fractionation (Fahey & Terry, 1978) .
Immunoblot analysis SDS/PAGE was carried out in 7-16 % (w/v) polyacrylamide gels as described by Laemmli (1970) . Proteins separated on SDS/polyacrylamide gels were electrophoretically transferred to nitrocellulose, as described by Towbin et al. (1979) . The Western blot was immunostained with a sheep anti-(rat microsomal glucose binding protein) IgG or an anti-(human erythrocyte glucose transport protein) IgG. Immunoreactive polypeptides were detected by using a biotin-streptavidin-peroxidase-linked detection system with 4-chloro-l-naphthol as the substrate (Mandrell & Zollinger, 1984; Domin et al., 1984) .
Determination of glucose transporter number
The number of D-glucose-inhibitable cytochalasin B-binding sites in the microsomal fractions was determined as previously described (Cushman & Wardzala, 1980) .
Photochemical cross-linking of membranes
Microsomal fractions, either intact or fully disrupted by deoxycholate as described by Burchell & Cain (1985) , were resuspended in 30 mM-Tris/HCl (pH 7.4) to a final concentration of 1-5 mg of membrane protein/ml. The membranes were incubated at 4°C for 10 min with [3H]cytochalasin B at a final concentration of 10 /M. The membranes were then photochemically cross-linked with hydroxysuccinimidyl-4-azidobenzoate (400 #M) by exposure to u.v. light (254 nm) for 2 min as previously described (Horuk et al., 1983) . Control experiments were as above, except that 500 mM-D-glucose was incubated with the membranes for 30 min before the addition of cytochalasin B.
Membranes covalently cross-linked to [3H]cytochalasin B were immediately solubilized by boiling for 4 min in Laemmli (1970) sample buffer and were then subjected to SDS/PAGE on a 7-16% gel. Radioactive bands were detected either by fluorography using 2,5-diphenyloxazole (PPO) (Bonner & Laskey, 1974) glucose transport protein (Baldwin et al., 1982) . Fig. 1 shows that two bands which are present in both rat and human microsomes cross-react weakly with the antibody. The molecular masses of the bands were approx. 52 kDa and 24 kDa.
Cytochalasin B is a potent reversible inhibitor of plasma membrane glucose transport proteins, and binding of cytochalasin B to these proteins is blocked by D-glucose. Cytochalasin B has been widely used as a probe to identify and characterize glucose transport proteins in plasma membranes (e.g. Lin & Spudich, 1974; Jung & Rampal, 1977; Baldwin et al., 1979; Shanahan, 1982 Shanahan, , 1983 Kasanicki etal., 1987; Wang, 1987; Chen & Lo, 1988; Oka et al., 1988) . The amount of cytochalasin B that inhibits erythrocyte plasma membrane glucose transport halfmaximally is 0.07-0.04 /LM (Jung & Rampal, 1977; Axelrod & Pilch, 1983) , whereas the K, of 1.9 gM for inhibition of hepatic plasma membrane glucose uptake is an order of magnitude higher (Axelrod & Pilch, 1983) . It had previously been reported that cytochalasin B does not inhibit D-glucose transport across the ER membrane (Arion et al., 1980) , although no details of the concentrations of cytochalasin B used were given, as this was a reference to other work which has not yet been published. We therefore carried out studies of cytochalasin B inhibition of glucose-6-phosphatase activity in intact microsomes. We found that cytochalasin B was a very poor inhibitor of glucose-6-phosphatase activity. However, very high levels (20 /LM) of cytochalasin B (an order of magnitude higher than are required for the plasma membrane glucose transport protein; see above)
did have a small inhibitory effect (mean 26 + 2 %) on glucose-6-phosphatase activity in intact microsomes, suggesting that cytochalasin B might bind weakly to T3, the proposed microsomal glucose transport protein of the glucose-6-phosphatase system. T3 is not normally the rate-limiting step of the glucose-6-phosphatase system in intact microsomes (Arion et al., 1980 (Ciaraldi et al., 1986) . The values obtained suggest that there is only a low number of glucose transport protein molecules in the microsomal membrane; however, we cannot rule out the possibility that all of the glucose transport molecules in the microsomal membrane may not be available for cytochalasin B binding. That this is a possibility has been suggested by two studies of the human erythrocyte transport protein. The degree of glycation of the erythrocyte transport protein has been shown to alter the ability of the protein to bind cytochalasin B (Bilan & Klip, 1990) . Secondly, the human erythrocyte glucose transport protein has been shown to bind to glyceraldehyde-3-phosphate dehydrogenase (Lachaal et al., 1990) . The fact that glucose transport proteins can bind to other proteins increases the possibility that T3 may be able to bind directly to other components of the glucose-6-phosphatase system. The way we purified T3 from a partially purified preparation of the glucose-6-phosphatase enzyme (see below) also indicates that this may be the case.
The second approach that was used to identify microsomal glucose transport protein(s) was to attempt to label such proteins with [3H]cytochalasin B in the presence and absence of glucose, as described by Horuk et al. (1983) for the labelling of plasma membrane glucose transport proteins. Fig. 2(a) shows that three peaks of radioactivity were observed in gel slices after SDS/PAGE. The first peak, which is of very high molecular mass ( > 100 kDa), is also seen in control microsomes and is presumably non-specific binding. The other two peaks, at 48-52 kDa and 22-24 kDa, were D-glucose-inhibitable and correspond well with those observed in Fig. 1 .
The labelling with cytochalasin B was very weak, as was expected from the studies of cytochalasin B inhibition of microsomal glucose-6-phosphatase activity. Fluorography of SDS gels revealed two bands of approx. 52 and 24 kDa, but the amount of labelling with [3H]cytochalasin B was so low that only faint bands were visible on the films (Fig. 2) .
The fact that two completely independent techniques both identified the same two bands of approx. 52 and 24 kDa as probable glucose binding or glucose transport proteins led us to attempt to purify the two proteins. Gel slice no. Fig. 2 . Photoaffinity labelling of microsomal protein with cytochalasin B (a) Photoaffinity cross-linking was carried out as described (Horuk et al., 1983 In order to confirm that the protein(s) purified had a role in the glucose-6-phosphatase system, we partially purified the glucose-6-phosphatase enzyme using sucrose gradients, as described in the Materials and methods section. It seemed possible that T3, the proposed glucose transport protein, might co-purify with the catalytic subunit activity of glucose-6-phosphatase during this procedure, as the regulatory stabilizing protein, the catalytic subunit protein and the T2 protein are all present in the pooled fractions. The pooled fractions were then purified further using an anti-(human erythrocyte glucose transport protein) IgG affinity column as described in the Materials and methods section. Only one protein, as judged by protein staining of SDS/polyacrylamide gels, bound to the column and was eluted with 0.1 M-glycine, pH 3.0. The purified protein, which had a molecular mass of 52 kDa, was used to raise an antiserum in sheep. The antiserum was monospecific for a single 52 kDa polypeptide in rat and human microsomes as judged by immunoblot experiments (Fig. 3) . The molecular mass of the band was found to be 52 kDa, as judged by SDS/polyacrylamide gel electrophoresis on 10 % (w/v) polyacrylamide gels. On gradient gels, e.g. Fig. 3 , which is a 7-16 % polyacrylamide gel, the apparent molecular mass of the band was somewhat variable. Other facilitated glucose transporters are well known to be glycated (e.g. see Bilan & Klip, 1990) . Assuming that the microsomal glucose transporter is also a glycoprotein, the carbohydrate content of the protein may contribute to the fact that its apparent molecular mass varies slightly depending on the precise percentage of acrylamide present in polyacrylamide gels.
In order to determine whether the 52 kDa polypeptide is a protein involved in the glucose-6-phosphatase system, the antiserum raised against the 52 kDa protein was incubated with intact rat liver microsomes. The antiserum inhibited the Vmax of glucose-6-phosphatase activity by up to 36 % (see Table 1 ), but had no significant effect on the Km of glucose-6-phosphatase in intact rat liver microsomes. The Km remained constant at 3.2 + 0.1 mM (n = 26) in the presence of both pre-immune and test antiserum (see Table 1 ). Addition of control pre-immune antiserum from the same sheep caused a small increase in glucose-6-phosphatase activity in intact microsomes. No Fig. 4 . Effect of anti-(52 kDa protein) antibody on rat hepatic nicrosomal 114Ciglucose-6-phosphate (G-6P) uptake
The graph shows the uptake of [14C]G-6-P into starved rat liver microsomes. Transport assays were carried out as described in Waddell et al. (1989) . Incubations were carried out in 40 mMcacodylate buffer/l mm-G-6-P/0.5 ,Ci of [U_14C]G-6-P/ml. Two controls (O, 0) contained 40 jug of preimmune serum/ml, while the test (0) contained 40,tg of anti-(52 kDa protein) antibody/ml. After 3 min (arrow), a chase of 25 mm unlabelled G-6-P was added to the test (0) and to one control (0). 6-phosphatase activity by the antiserum indicates that the 52 kDa polypeptide has a role in glucose-6-phosphatase activity. Inhibition of T3 would lead to an increase in the glucose concentration inside the lumen of the ER. Glucose is a noncompetitive inhibitor of the glucose-6-phosphatase enzyme (e.g. see Arion et al., 1980) , so the increased luminal glucose would inhibit glucose-6-phosphatase in intact microsomes, resulting in a decreased Vmax as seen in Table 1 . The small Vmax inhibition caused by the antiserum is therefore compatible with the 52 kDa glucose binding and/or transport protein being T3. Direct transport assays with glucose-6-phosphate as substrate were carried out as previously described (Waddell & Burchell, 1987; Waddell et al., 1989) . Fig. 4 shows that the antiserum raised against the 52 kDa protein decreases the rate of ['4C]glucose release from starved rat liver microsomes which have been incubated with ['4C]glucose 6-phosphate, followed by the addition of 25 mm non-radioactive glucose 6-phosphate.
In conclusion, the 52 kDa protein that we have purified from rat liver microsomes is a glucose transport protein that plays a role in the activity of glucose-6-phosphatase in intact rat liver microsomes. It is therefore most probably T3, the glucose transport protein of the glucose-6-phosphatase system. The very weak binding of cytochalasin B to the 52 kDa protein compared with the binding of other plasma membrane glucose transport proteins suggests that the microsomal 52 kDa protein (T3) is a novel glucose transport protein. It will be necessary to isolate a full-length rat liver cDNA coding for the 52 kDa protein to establish its similarity to the plasma membrane glucose transport proteins (GLUTs 1-5) (Bell et al., 1990) and for use in studies of type 1 glycogen storage disease patients. Further studies must also be undertaken to purify the 24 kDa microsomal protein, which binds cytochalasin B and cross-reacts with anti-(erythrocyte glucose transport protein) antibody but not with the antibody raised against the 52 kDa microsomal protein, to determine whether it also is needed for normal glucose-6-phosphatase activity in intact microsomes.
